chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am feeling unusually weak and fatigued but what is bothering me even more is a ?deep sighing? felt more like a skipped breath. Is this an unusual report. It is really weird. I mentioned to my daughter who also got the Pfizer and she said I should take deep breaths but then it keeps coming back..  I had a visit with another doctor 2 days ago and I did mention it. He asked about other s/s like SOB  and  I said no. But this deep sighing even wakes me up at night.  What do I do?
Patient came by the Pharmacy today (7/25/18) complaining of a sore arm with redness and itching. She stated that the soreness had been pretty constant since receiving the vaccination, but the redness and itching started on tuesday morning (7/24) as far as she can remember. All symptoms are isolated to the injection site. I advised the patient to followup with her PCP as soon as possible. She reported no signs of a systemic reaction.
DOSES OF COVID-19 VACCINE EXPERIENCED TEMPERATURE EXCURSION AND WAS ADMINISTERED; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202F21A expiry: 07-FEB-2023) dose, start therapy date were not reported for covid-19 prophylaxis. The drug was associated with Medication error. No concomitant medications were reported. On an unspecified date, the patient experienced doses of covid-19 vaccine experienced temperature excursion and was administered, and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the doses of covid-19 vaccine experienced temperature excursion and was administered and incorrect product storage was not reported. This report was non-serious.
This spontaneous report as received from a Certified Medical Assistant refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with an improperly stored dose of ROTATEQ oral (dose, lot number and expiry date were not reported). No adverse effects reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information is not expected, because the reporter refused additional contact.
Patient came to pharmacy to get a Janssen Covid Vaccine.  He did not inform staff that he had already received a Janssen vaccine in March 2021.     NO adverse event reported by patient after second dose received.
Vein bulging initially with leg weakness.  Then in 2023 after having COVID, severe headaches and loss of vision, chest pain and back pain
Hives on ears, swollen lymph nodes, ears hot and very itchy, later hives spread to face, neck and arms. was given prednisone and cream. still have some residual itching and swollen lymph nodes.
pain at injection site (3 days), fever (1 day), chills (12 hours), joint pain (12 hours), fatigue (2 days), headache (12 hours), stomach ache (8 hours)
Five minutes after injection, experienced a hot flash and increased hart rate, accompanied by dizziness; Five minutes after injection, experienced a hot flash and increased hart rate, accompanied by dizziness; Five minutes after injection, experienced a hot flash and increased hart rate, accompanied by dizziness; Headache persisted for 2 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 15:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia, vitamin D deficiency, cilantro (food allergy), sulfa (sulfonamide allergy) and peanut allergy. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and antimony potassium tartrate, pulsatilla pratensis, bryonia alba, drosera rotundifolia, psychotria ipecacuanha, dactylopius coccus, rumex crispus, lobaria pulmonaria, euspongia officinalis (CHESTAL BERRY); both for unknown indications and on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 15:05, five minutes after vaccination, the patient experienced a hot flash and increased heart rate, accompanied by dizziness. The patient was treated with water and sitting. On 07Apr2021, after returning to normal, the patient experienced headache which persisted for 2 hours. On 07Apr2021, the patient underwent lab tests and procedures which included heart rate and the result was high. Events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events hot flash, increased heart rate, dizziness and headache was recovered on 07Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After each dose of the vaccine I experienced atrial fibrillation for a number of days,; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 12Mar2021 at 08:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 02Apr2021 at 08:00 as dose 2, single (Lot number: FW0150), in left arm, on 12Nov2021 at 08:00 as dose 3 (booster), single (Lot number: FE3690), in left arm and on 17May2022 at 17:30 as dose 4 (booster), single (Lot number: FM9998) at the age of 52 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Atrial fibrillation" (unspecified if ongoing); "Prostate cancer" (unspecified if ongoing); "Known allergies: Latex" (unspecified if ongoing); "Known allergies: Adhesive" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL. Vaccination history included: ajovy (Other vaccine 4weeks dose number=2, Other vaccine 4weeks vaccine location=Left leg), administration date: 16May2022, when the patient was 52-year-old, for Immunization. The following information was reported: ATRIAL FIBRILLATION (medically significant) with onset 18May2022 at 22:00, outcome "recovering", described as "I have a pre-existing condition, atrial fibrillation, controlled by Metoprolol with no symptoms. After each dose of the vaccine I experienced atrial fibrillation for a number of days, until it eventually subsides". Therapeutic measures were not taken as a result of atrial fibrillation.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
dose adminstered that was not stored properly; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (dose adminstered that was not stored properly) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, the patient experienced PRODUCT STORAGE ERROR (dose adminstered that was not stored properly). At the time of the report, PRODUCT STORAGE ERROR (dose adminstered that was not stored properly) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was unknown   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up was received on 15-JUN-2021. Reporter information was updated.
10 min after second dose vaccine, she felt tightness in her chest.  Patient has history of Asthma and self medication with albuterol inhaler.  O2 Sats, BP and Pulse all normal through observation period.  Patient was observed for an additional 30 min.  No further need of albuterol and left with chest clear with no wheezing
Pain in Left side of neck (on side of vaccine) when turned both left and right (more pain when turned to left); pain in Left shoulder when reaching across and placing hand on right arm.
Injection Site Soreness day 2-3 Narrative:  Other Relevant History:
Throat closure sensations beginning mildly 30 minutes after shot and persisting/progressing at least 15 hours later.
Very bad headache; Extreme fatigue; This is a spontaneous report from a contactable consumer, the parent. A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration and anatomical location on 17Mar2021 at 09:00 (at the age of 23-years-old), as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food or other products. Medical history was not reported. Concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 15:00, the patient experienced very bad headache and extreme fatigue. The patient received no treatment for the very bad headache and extreme fatigue. The clinical outcome of the very bad headache and extreme fatigue was resolved in Mar2021.   Information about lot number cannot be obtained. No further information is expected.
Dose 2 :Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Dose 2 :Flu like symptoms) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 045A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020. Family history included Heart failure (NOS) (Patient husband has a heart failure condition, and she works in a construction company and is at high risk).   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Dose 2 :Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Dose 2 :Flu like symptoms) had resolved.            No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-358827 (Patient Link).
chills; fever; malaise; body aches; overall feeling of not wanting to get out of bed; in Nov 2019, the patient received the first dose of Shingrix, however did not return; This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 16th November 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced chills, fever, malaise, general body pain, somnolence and incomplete course of vaccination. The patient was treated with ibuprofen. On an unknown date, the outcome of the chills, fever, malaise, general body pain and somnolence were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the chills, fever, malaise, general body pain and somnolence to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported for 1st dose and was not applicable for 2nd dose. The reporter stated that, the patient experienced COVID like symptoms after 1st dose. The reporter stated that, the patient got the shot in afternoon. The next morning woke up with symptoms by the next day they were resolved. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
Positive COVID test after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID test after 1st dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced COVID-19 (Positive COVID test after 1st dose). At the time of the report, COVID-19 (Positive COVID test after 1st dose) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.  The patient did not have any symptoms, she was exposed and then got tested.
28 DAYS POST INJECTION, PATIENT STILL HAS A LUMP UNDER THE SKIN AND MILD BRUISE AT INJECTION SITE
After the first shot I had intermittent pain along the left side of my jaw, as well as intermittent pain on the left side of my chest. This sometimes would extend to my back. The chest pain was less often and less noticeable of the two.  This lasted for a few weeks following the first shot. While I did have chest tightness.. I do not recall having the same sensations in my left jaw or chest following the second shot, but I did not write my symptoms down. In addition, I have seasonal allergies that were bad during the month of April and it is sometimes difficult to tell whether chest/lung tightness is related to that. I am now having what feels like heart palpitations or racing heartrate, particularly at night, sometimes during exertion, or if I have not slept well. I do not know that the heart palpitations are related to the vaccine, but I do believe the jaw and chest pain are attributable to it.
No symptoms on 1/8. Saturday 9pm inj site was sore. 1/10, 3pm, began to get a headache, terrible, banger of a headache,  took Tylenol.  Headache all night long. 1/11 2am got nauseated to the point of vomiting. Runny nose and coughing. Finally woke up this am with muscle pain. The headache is better, but still feels pressure.  Feels bad all over, flu like, flushed, feverish.  Right kidney pain,  started today.
Hive like reaction, inflammation, red, warm to touch, raised bumps, itchy. RA inner hive circle 1 1/2" length and width, outer circle 3" width 6" length. LA 3 3/4" length, 4" width. Treatment Prednisone 5mg or 10mg x 4 days.
Tachycardia; Irregular heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia) and HEART RATE IRREGULAR (Irregular heartbeat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (Tachycardia) and HEART RATE IRREGULAR (Irregular heartbeat). At the time of the report, TACHYCARDIA (Tachycardia) and HEART RATE IRREGULAR (Irregular heartbeat) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  No concomitant medication information was reported. No treatment medication information was reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Not all or limited to: anaphylactic reaction:  Feeling lump in throat, tongue feeling funny with numbness, feeling of hard to swallow, throat tightness, shortness of breath, tachycardia, tachypnea, pressure, tingling, and numbness from head to toe, dizziness/lightheartedness, cough, voice changes.
On Wednesday morning, I awoke and saw a red rash on my left arm around the site of the injection.
No adverse event. Administered CSL AFLURIA Lot #1549211A  to a 17 yr. old patient. Vaccine is intended for use on 18 yr. old and older. Patient waited 20 minutes and reported no side effects.
Took a home test 9/02/21 and was positive. Started coughing on 8/30/2021 and on 08/30/21 had severe head congestion, sneezing, coughing, fatigue.
NO ADVERSE EVENT: JUST REPORTING AS PER PUBLIX PHARMACY QRE PROTOCOL : ADMINISTERED VACCINATION AFTER BEYOND USE DATE OF 07/19/2023
This case was reported by a other health professional via call center representative and described the occurrence of injection site rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 3 days after receiving SHINGRIX, the patient experienced injection site rash and erythro papular rash. On an unknown date, the outcome of the injection site rash was not recovered/not resolved and the outcome of the erythro papular rash was unknown. It was unknown if the reporter considered the injection site rash and erythropapular rash to be related to SHINGRIX. Additional details were provided as follows; The health care professional stated that patient developed a rash at injection site after 1st dose of SHINGRIX. The patient reported to health care professional that they developed a red, bumpy rash at injection site 3 days or so after 1st dose of SHINGRIX. It was still un-resolved at the time of reporting. The health care professional was unable to provide very much detail because the vaccine was not administered at their site. The reporter requested to follow-up with health care professional for further details as no other information was provided.
Chills fever and fatigue one day after receiving second covid vaccine shot; Chills fever and fatigue one day after receiving second covid vaccine shot; Chills fever and fatigue one day after receiving second covid vaccine shot; This is a spontaneous report received from a contactable consumer (patient). A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot/batch number not provided), via an unspecified route of administration on an unspecified date (at unknown age) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced Chills, fever and fatigue one day after receiving second COVID vaccine shot. Event took place after use of product. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
post herpetic neuralgia; herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 63 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or around 25-SEP-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster and post herpetic neuralgia. On an unspecified date, the patient was treated by a healthcare provider for herpes zoster and post herpetic neuralgia. The outcome of the events herpes zoster and post herpetic neuralgia was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
same noc as shot, lethargy, wheeze, pasley like rash on bottom & legs; ?fever, then got sores w/crusts on legs; wounds were oozing tx w/Cortaide helped;
This spontaneous report received from a health care worker refers to a patient of unknown demographics. No medical history was reported. On an unknown date the patient was vaccinated with an improperly stored  GARDASIL 9 (lot # L011846, expiry date: 16-JUN-2017, dose and route: unknown) and (Merck) VARIVAX (lot # L007224, expiry date: 03-MAR-2017, dose and route: unknown). No other concomitant therapy was reported. This case is linked to cases: # 1509USA011273 and # 1509USA007856. (Same reporter link). Additional information has been requested.
Approx. 10am child in for varicella vaccine. SQ injection given. Child received vaccine fine, when parent and child went up front there was a call for "nurse up front." I was the firs to come to the scene, the  patient/child sitting up in moms arms, eyes open and lips pale. Child sat in wheelchair to the back and given juice and crackers. She felt better within a couple of minutes no knot was noted but ice patient was given. Instructed to have breakfast before vaccination in the future.
Five patients being administered doses from a vial left out overnight from 12/20/21 to 12/21/21\administered beyond the 12 hours use times; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Five patients being administered doses from a vial left out overnight from 12/20/21 to 12/21/21\administered beyond the 12 hours use times) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H21A) for COVID-19 vaccination.     Concurrent medical conditions included Ulcerative colitis, Anemia and Hyperlipidemia. Concomitant products included SERTRALINE, ROSUVASTATIN and LORAZEPAM for an unknown indication.    On 21-Dec-2021 at 9:51 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Dec-2021 at 9:51 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Five patients being administered doses from a vial left out overnight from 12/20/21 to 12/21/21\administered beyond the 12 hours use times). On 21-Dec-2021 at 9:51 AM, EXPIRED PRODUCT ADMINISTERED (Five patients being administered doses from a vial left out overnight from 12/20/21 to 12/21/21\administered beyond the 12 hours use times) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Medical History information was reported. No treatment medication was reported.   This case was linked to MOD-2021-422292 (Patient Link).